Our people, our value
We strive every day to build a safe and welcoming work environment that is open and inclusive. We value skills, creativity and talent; we encourage participation and awareness, and we invest in training people.
Mirjam Gegner
HSE Manager - Bad Königshofen plant
“We believe that safety culture should be a shared mindset where everyone feels empowered. To achieve this, daily interaction and direct conversations with people are the first steps towards conscious and safe behaviour in the workplace.“
Alexander Schawohl
Head of Assembly - Hinternah plant
“At our Hinternah plant in Germany, we manufacture and assemble thousands of closures and dosing accessories every day for pharmaceutical use. To manage this demanding flow, precision and production speed are the driving force.“
Elisa Giordano
Accounting Supervisor - HQ
“Dealing with administrative processes requires strong analytical and detail-oriented skills, but only when these are combined with incisive management and communication abilities, important results can be achieved.“
Marco Bauer
Siliconization Team Leader – Bad Königshofen Plant
“Supervising complex production processes presents me with demanding, stimulating and ever-different daily challenges. Thanks to the full trust of colleagues and an open climate of collaboration, I feel supported in guiding my team on a journey of continuous improvement and growth.“
Maria Teresa Ritucci
Assembly Line Operator and Finished Product Inspector – Vasto Plant
“In my work, precision and accuracy really make a difference. Every day, I pay attention to even the smallest details to contribute to the creation of safer products intended for the care of people.“
Francesca Pintabona
Plant Quality Assurance & Regulatory Specialist - HQ
“For me, quality is a model, a way of thinking and behaving, in which the whole organisation is called to account for its actions, which focuses on the constant optimisation of production processes and the constant monitoring of customer satisfaction.“
Giovanni Botto
Compression Department Supervisor - Rivanazzano plant
“Coordinating a department that produces over 2 million pieces a day is undoubtedly a great challenge. As a supervisor, I am committed to guiding my colleagues with motivation and valuing their strengths, in order to make them face such a fast-paced environment, always focusing on optimizing the final result.“
Federico Piutti
Innovation Manager - HQ
“My commitment is to find new ways of generating innovation, disseminating inventive thinking within the company and creating an ecosystem of innovators on the outside. Through an open dialogue with customers, which begins from the earliest stages of product development, we transform ideas into real solutions.“
Chiara Verzelloni
Production Manager – Bergantino Plant
“Being one of the youngest production managers in my company is both a huge challenge as well as something I am very proud of. The recognition of merit and the nurturing of talent were essential in giving me the determination necessary to take on such an important role.“
Moustapha Mamadou Soussang
Quality Controller – Saint Sulpice Plant
“Thanks to an opportunity for company rotation between Italy and France, my experience with Bormioli Pharma has been enhanced by opportunities and stimulation. The constant exposure to different contexts, together with a wider sharing of skills, has allowed me to make my professional profile even more complete.“
Claudia Monfredini
Environmental & Sustainability Manager - HQ
“At Bormioli Pharma, people's safety and respect for the environment are not just a set of rules, but are ways of acting and understanding our work, part of a shared culture. From the simplest actions to the most complex procedures, we all feel a responsibility to reduce waste and to promote sustainable practices for communities and the ecosystem.“
Our approach
—Rewarding merit
Our performance evaluation model is based on the definition of shared goals, transparent feedback, and identification of individual potential capabilities. This allows for active discussion based on professional and personal growth.
—Work-life balance
The adoption of flexible working arrangements, together with the introduction of tools to support parenting, enable us to ensure productivity while respecting the work-life balance.
—Welfare
Through a structured system of benefits, partnerships and collaborations with business, healthcare and institutional entities, we promote the well-being of our people.
—Training
We encourage and support continuous improvement and learning through training plans and paths for professional and managerial development.
—Growth
We make diversified professional opportunities accessible to all, enabling them to broaden skills and develop talent.
—Inclusiveness
We believe in promoting diversity and inclusion as an opportunity to create value. Introducing new, more varied and extended competencies enriches corporate culture.
—Security and sustainability
We promote virtuous risk prevention behaviors and ensure safe working conditions. We strive to reduce environmental impact through the sharing of responsible conduct.
Security as a way of being
We believe that safety culture should be a participatory implementation of best practices. Prevention, adherence to procedures and training are all part of the shared journey we have embarked on, putting people at the center, as the value and main drivers of change.
A community that continues to grow
In recent years we have boosted training and seen our community grow, with further diversification of cultures and home territories.
8731
training hours
1400+
people
from 350
city
10+
languages spoken
25%
under-30s among new hires
One year in Bormioli Pharma
The most recent news
Bormioli Pharma partners with Chiesi to supply the first pharma primary packaging in Carbon Capture PET
Bormioli Pharma today announced a partnership with Chiesi, an international, research-focused biopharmaceutical company (Chiesi Group), to supply Carbon Capture PET bottles. These will be used to package a medication indicated for the prophylaxis and treatment of seasonal and perennial allergic rhinitis, as well as vasomotor rhinitis.
Bormioli Pharma presents its wide primary pharma packaging offer at CPHI Milan 2024, focusing on cutting-edge sustainable and high-quality solutions for the pharma industry
From 8th to 10th October in Milan (Fiera Milano, booth 20A2), the company will showcase EcoPositive, one of the widest pharma-grade low impact product ranges available on the market, featuring over 3,000 items.
Bormioli Pharma and Asamedic Announce Partnership for Life-Saving Drug Coxor™
Asamedic, a pioneer in emergency medical treatment of myocardial infarction, and Bormioli Pharma announce their partnership for the commercialization of Coxor™ 300mg Acetylsalicylic acid, revolutionary life-saving medication designed for emergency treatment of suspected acute myocardial infarction.
Bormioli Pharma achieves the “Gold Medal” in EcoVadis ESG scorecard
This important recognition places the leading pharma packaging manufacturer in the top 5% of all evaluated companies, showing improved performances on environmental safeguarding, workplace practices and corporate ethics.
Independent research demonstrates the extreme safety of Bormioli Pharma’s bottles manufactured with Loop Industries’ 100% recycled, virgin quality PET
Developed from PET resin supplied by Loop Industries, Inc., the containers have extractables values well below even conventional solutions in virgin PET under the most challenging conditions.
Bormioli Pharma launches the 3rd edition of its ESG Report, reaching the 45% of sustainable materials in sold products with its EcoPositive range
Bormioli Pharma announced today the third edition of its Sustainability Report. This edition outlines and consolidates the strong progress Bormioli Pharma has made in promoting sustainable growth in the communities where the Company live and work and highlights its strong commitment to supporting the pharmaceutical industry in its transition towards environmentally friendly solutions.
Bormioli Pharma and Loop Industries unveil an innovative pharmaceutical packaging bottle manufactured with 100% recycled virgin quality Loop PET resin at Pharmapack 2024
This packaging innovation will be showcased at Pharmapack Europe 2024 (24th-25th January, Paris Expo, Porte de Versailles - booth B78-B79, Hall 7.2)
Bormioli Pharma introduces at Pharmapack Europe 2024 a brand-new consultancy approach showcasing its wide, sustainable and innovative packaging offer
Bormioli Pharma will attend Pharmapack Europe 2024 in Paris (Paris Expo, Porte de Versailles - booth B78-B79).
Bormioli Pharma together with Desall.com to digitise package leaflets using augmented reality
The project is part of the Bormioli Pharma Invents innovation programme, which aims to provide concrete answers to some of the most important challenges in the pharmaceutical packaging sector.
Bormioli Pharma presents at CPHI Barcelona 2023 a future-ready packaging solution offering, integrating advanced services, IoT technologies and sustainability.
The company displays its wide portfolio of product and services in Barcelona from 24th to 26th of October (Fira Barcelona Gran Via, Booth 2K30, Hall 3.0).
Bormioli Pharma names the winner of one of the contests launched with Desall
The competition, which aimed to innovate traditional CRC locking systems through the introduction of biometric technologies, attracted 37 design proposals from 24 countries worldwide.
Bormioli Pharma launches the "Plastic Academy"
The academy aims to train professionals specialised in the processing of plastics.
Inclusive and accessible pharmaceutical packaging: a necessity for vulnerable patients
Inclusive and accessible pharmaceutical packaging is designed to provide user-friendly packaging for vulnerable patients too. Learn more about the solutions currently on the market, but also about future prospects for development and application.
Bormioli Pharma announces two new call4ideas with Desall.com to imagine the future of pharmaceutical packaging
The two contests aim to explore how two digital technologies, such as augmented reality and biometric recognition, can impact the future of pharmaceutical packaging, improving drug delivery and patient safety. In addition to receiving a monetary prize, the winners will have the opportunity to contribute to the development of their project.
Bormioli Pharma reaffirms its commitment to environmental and social sustainability with the presentation of the 2nd edition of its ESG Report
One of the main objectives is to cut CO2 emissions by 30% by 2030, while the target for the reduction of water consumption has been redefined (from -30% to -41%) in light of the significant improvements already achieved in 2022.
Bormioli Pharma and IQVIA Italy together to identify patients’ real needs
Patients' usage habits regarding injectables and topicals were investigated by means of one-to-one interviews and focus groups. The investigation brought to light critical issues and potential areas for development.
Bormioli Pharma Grows North America Sales by More Than 40% in 2022 While Mobilizing a Multimillion Dollar Investment Program to Expand its Packaging Solutions for Parenteral Drugs
The company has invested in strengthening its tubular glass vials capabilities through advanced machinery, while upgrading its platform for molded glass, and expanding clean-room capabilities for the production of rubber stoppers.
Bormioli Pharma presents at Pharmapack Europe the evolution of its pharma packaging offer, focused on sustainability and new IoT technologies
The company will display its wide product range in Paris on 1st-2nd February (Porte de Versailles Expo, booth A68-A70). Bormioli Pharma will also showcase new prototypes, among which a connected medical device able to administer ophthalmic drugs through nebulization.
New scientific evidence shows that tubing glass vials and “Delta” molded glass vials provide comparable performance
Bormioli Pharma has launched an experimental investigation to compare properties and performance between two types of 10 ml and 30 ml vials in 'Delta' molded glass and tubing glass: the results show that both solutions provide comparable benefits, depending on the drug and the production processes for which they are intended.
Bormioli Pharma and Pierre Fabre develop a 100% recycled PET packaging for ELUDRIL® brand mouthwashes
Bormioli Pharma and Pierre Fabre, a French pharmaceutical and dermo-cosmetic group present in more than 100 countries, are consolidating their partnership started in 2020 through an innovative initiative in eco-design and sustainable development.
Bormioli Pharma reveals at CPHI Frankfurt new prototypes focusing on effective, patient-centered innovation
Bormioli Pharma will attend at CPHI in Frankfurt (booth 30B20) showcasing a service-driven, innovative and sustainable product offer and reaffirming its positioning as “one-stop shop” partner for the pharma industry.
Bormioli Pharma issues its first ESG Report. Among the main objectives: -30% water consumption and CO2 emissions by 2030, 50% use of sustainable raw materials in production
Bormioli Pharma has published its first Sustainability Report according to ESG criteria, a document that reports on the Group's activities in terms of social responsibility during 2021 and that sets medium and long-term improvement objectives in line with its mission: "Making health a positive practice, accessible to all and kind to the planet".
Bormioli Pharma presents groundbreaking scientific data that show the undeniable safety of sustainable plastic packaging for medicines
Bormioli Pharma has presented a set of data highlighting that pharma-grade, sustainable plastic packaging is able to fulfill the strictest requirements of the industry in terms of quality and safety.
Bormioli Pharma launches at Pharmapack Europe “EcoPositive”, a new range of planet-friendly packaging solutions
Bormioli Pharma announces the launch of EcoPositive, a brand new label gathering all the sustainable packaging solutions manufactured by the company.